Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis

Accession: GSE98782
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, 17021
Organism: mouse
Samples: 8
Size (indexed): (None bytes)
Downloaded bytes: 33.2 MB (34821422 bytes)
Access / raw: public /

Download

Files

FileSizeSHA256
GSE98782_TreatedKC_UntreatedKC.xlsx6.9 MBcec7fdfa8d6fce87…
GSE98782_TreatedMO_TreatedKC.txt.gz489.0 KBdcb0a90974d1de8c…
GSE98782_TreatedMO_TreatedKC.xlsx7.2 MBa0956b7f19946acc…
GSE98782_TreatedMO_UntreatedMO.xlsx9.1 MB0cd1d5d3ee8adb61…
GSE98782_UntreatedMO_UntreatedKC.xlsx9.5 MB4500c4126559d005…

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T08:55:27Z.

About this dataset

This Expression profiling by high throughput sequencing, 17021 dataset provides single-cell gene expression from mouse liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 8 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.